(Q38334595)

2 September 2017

title

Aptamer inhibits Mycobacterium tuberculosis (H37Rv) invasion of macrophage (English)

1 reference

Mycobacterium tuberculosis

2 September 2017

0 references

0 references

author name string

Fan Chen

1

1 reference

2 September 2017

Xiaolian Zhang

2

1 reference

2 September 2017

Jing Zhou

3

1 reference

2 September 2017

Shengwu Liu

4

1 reference

2 September 2017

Junyan Liu

5

1 reference

2 September 2017

language of work or name

1 reference

4 June 2011

1 reference

2 September 2017

number of pages

6

1 reference

Molecular Biology Reports

inferred from page(s)

published in

1 reference

2 September 2017

volume

39

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

2157-2162

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-011-0963-3

2 September 2017

exact match

0 references

cites work

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Update in tuberculosis 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Prospects for a better vaccine against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Tuberculosis in HIV-infected patients: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

The Envelope of Mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Mycobacterial outer membranes: in search of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Aptamers evolved from live cells as effective molecular probes for cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Oligo oligarchy-the surprisingly small world of aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Mycobacterium tuberculosis: here today, and here tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

The Cell Biology of Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Production of interferon-gamma by myeloid cells--fact or fancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Immunology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-0963-3

Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis

21 January 2018

1 reference

12 December 2020

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Aptamers: an emerging class of molecules that rival antibodies in diagnostics

1 reference

12 December 2020

Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages.

1 reference

12 December 2020

10.1007/S11033-011-0963-3

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1028221236

0 references

1 reference